Characterisation RyR1 variants linked to malignant hyperthermia : a thesis presented to Massey University in partial fulfilment of the requirements for a Masters of Science in Biochemistry
Loading...
Date
2016
DOI
Open Access Location
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Massey University
Rights
The Author
Abstract
Malignant hyperthermia is a potentially fatal disorder of skeletal muscle manifesting
as a rise in body temperature in response inhalational anaesthetics and muscle
relaxants. Further clinical signs include muscle rigidity and increased oxygen
consumption. The increased metabolism is induced by alterations to Ca2+
homeostasis resulting from the dysregulation of the sarcoplasmic reticulum protein
the ryanodine receptor type 1 (RyR1). A large proportion of known malignant
hyperthermia linked genetic variants reside within the gene encoding the type 1
ryanodine receptor, RYR1. Malignant hyperthermia can be diagnosed by in vitro
contracture testing of biopsied muscle tissue. The use of DNA diagnostic testing is
advantageous, however it is limited to only 35 of the proposed 400 RYR1 linked
variants known to be associated with malignant hyperthermia.
The research described in this thesis reports the functional characterisation of two
RYR1 variants linked to malignant hyperthermia, c.641C>T and
c.7042_7044delCAG resulting in the amino acid changes p.T214M and p.ΔE2348.
The ability of each variant to release Ca2+ in response to a stimulus was examined in
a heterologous system. The variant p.ΔE2348 was shown to be hyperactive in
response to agonists indicating the variant is the cause of malignant hyperthermia,
while the p.T214M variant does not appear to have an effect ryanodine receptor
function.
To understand the relationship between RyR1 function and any structural alterations
induced by the p.T214M and p.ΔE2348 variants, the domain housing each variant
was cloned for bacterial expression. Subsequent purification and structural
characterisation could be used to explain the role each variant plays with respect to
the onset of MH. The RyR1 N-terminal domain, amino acids 1-558, and helical
domain, amino acids 2091-2525, were expressed in E. coli and partially purified. The
domains were shown to be soluble and stable following expression.
Description
Keywords
Malignant hyperthermia, Genetic aspects, Ryanodine receptors, Research Subject Categories::MEDICINE::Chemistry::Biochemistry